Got it - sorry if I sounded rude. I do think this could be the next Humera, I have even told Nader that I feel this is a Polio vaccine level drug. However, I don't think too much about the Humera comparison mostly because I would like to see the SP reflect just the combo HIV market potential first! It is just crazy to think that in around 6 months or less this will be generating revenue equal to the value of the company now every couple months just from the combo indication!